| Literature DB >> 32928198 |
Molly Rosenberg1, James Akiruga Amisi2,3, Daria Szkwarko2,4,5,6, Dan N Tran2,7, Becky Genberg8,9, Maya Luetke10, Sina Kianersi10, Jane Namae11, Jeremiah Laktabai2,3, Sonak Pastakia2,7.
Abstract
BACKGROUND: Structural barriers often prevent rural Kenyans from receiving healthcare and diagnostic testing. The Bridging Income Generation through grouP Integrated Care (BIGPIC) Family intervention facilitates microfinance groups, provides health screenings and treatment, and delivers education about health insurance coverage to address some of these barriers. This study evaluated the association between participation in BIGPIC microfinance groups and health screening/disease management outcomes.Entities:
Keywords: Health insurance; Health screening; Kenya; Microfinance
Mesh:
Year: 2020 PMID: 32928198 PMCID: PMC7491169 DOI: 10.1186/s12913-020-05712-6
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Fig. 1Conceptual model of the BIGPIC Family intervention components
Characteristics of the study population of 300 residents of two communities in rural western Kenya, 2018–2019
| Microfinance group membershipa | ||||
|---|---|---|---|---|
| Total | Yes | No | ||
| N (%) | N (%) | N (%) | ||
| | < 0.0001 | |||
| Male | 112 (37.3) | 19 (19.0) | 93 (46.5) | |
| Female | 188 (62.7) | 81 (81.0) | 107 (46.5) | |
| | 0.0006 | |||
| < 20 | 24 (8.0) | 1 (1.0) | 23 (11.5) | |
| 20–29 | 51 (17.0) | 11 (11.0) | 40 (20.0) | |
| 30–39 | 68 (22.7) | 32 (32.0) | 36 (18.0) | |
| 40–49 | 76 (25.3) | 30 (30.0) | 46 (23.0) | |
| 50+ | 81 (27.0) | 26 (26.0) | 55 (27.5) | |
| | < 0.0001 | |||
| Never married | 45 (15.1) | 1 (1.0) | 44 (22.1) | |
| Currently married | 219 (73.2) | 84 (84.0) | 135 (67.8) | |
| Divorced/separated | 35 (11.7) | 15 (15.0) | 20 (10.1) | |
| Missing | 1 | 0 | 1 | |
| | 0.2 | |||
| None/ Some primary | 92 (30.7) | 31 (31.0) | 61 (30.5) | |
| Primary | 116 (38.7) | 45 (45.0) | 71 (35.5) | |
| Secondary | 69 (23.0) | 20 (20.0) | 49 (24.5) | |
| Post-secondary | 23 (7.7) | 4 (4.0) | 19 (9.5) | |
| | 0.4 | |||
| Yes | 59 (19.7) | 17 (17.0) | 42 (21.1) | |
| No | 240 (80.3) | 83 (83.0) | 157 (78.9) | |
| Missing | 1 | 0 | 1 | |
| | 0.7 | |||
| Q1 | 70 (25.6) | 21 (23.6) | 49 (26.5) | |
| Q2 | 70 (25.6) | 27 (30.3) | 43 (23.2) | |
| Q3 | 61 (22.3) | 19 (21.4) | 32 (22.7) | |
| Q4 | 73 (26.6) | 22 (24.7) | 51 (27.6) | |
| Missing | 26 | 11 | 15 | |
| | 0.2 | |||
| Yes | 33 (11.0) | 14 (14.1) | 19 (9.5) | |
| No | 266 (89.0) | 85 (85.9) | 181 (90.5) | |
| Missing | 1 | 1 | 0 | |
| | 5.0 (2.27) | 5.2 (2.37) | 4.8 (2.21) | 0.2 |
| | < 0.0001 | |||
| Yes | 252 (84.0) | 96 (96.0) | 156 (78.0) | |
| No | 48 (16.0) | 4 (4.0) | 44 (22.0) | |
| | < 0.0001 | |||
| Yes | 124 (41.3) | 77 (77.0) | 47 (23.5) | |
| No | 176 (58.7) | 23 (23.0) | 153 (76.5) | |
| | < 0.0001 | |||
| Yes | 191 (63.7) | 96 (96.0) | 95 (47.5) | |
| No | 109 (36.3) | 4 (4.0) | 105 (52.5) | |
| | 0.0001 | |||
| Yes | 31 (10.3) | 20 (20.0) | 11 (5.5) | |
| No | 269 (89.7) | 80 (80.0) | 189 (94.5) | |
| | 0.005 | |||
| Yes | 36 (19.2) | 23 (28.4) | 13 (12.2) | |
| No | 152 (80.9) | 58 (71.6) | 94 (87.9) | |
| | 0.1 | |||
| Yes | 23 (71.9) | 10 (90.9) | 13 (61.9) | |
| No | 9 (28.1) | 1 (9.1) | 8 (38.1) | |
| | 0.1 | |||
| Yes | 17 (53.1) | 8 (72.7) | 9 (42.9) | |
| No | 15 (46.9) | 3 (27.3) | 12 (57.1) | |
*p-value reported for chi-square test for categorical variables and t-test for continuous variables. P-values calculated among observations with non-missing values
aMember of BIGPIC Family microfinance group for at least 6 months prior to interview
bMeasured by adding up the self-reported value (at time of purchase) of 20 key items in participant’s household
Relationship between microfinance group membership, health screening, and disease management, among 300 residents of two communities in rural western Kenya, 2018–2019
| Unadjusted | Adjusteda | |||||
|---|---|---|---|---|---|---|
| PR | aPR | |||||
| Current NHIF coverage | 1.49 | (0.78, 2.84) | 0.2 | 1.26 | (0.64, 2.47) | 0.5 |
| HIV screening | 1.23 | (1.13, 1.34) | < 0.0001 | 1.11 | (0.96, 1.29) | 0.2 |
| Diabetes screening | 3.28 | (2.50, 4.30) | < 0.0001 | 3.46 | (2.60, 4.60) | < 0.0001 |
| Hypertension screening | 2.02 | (1.74, 2.35) | < 0.0001 | 1.96 | (1.56, 2.46) | < 0.0001 |
| Tuberculosis screening | 3.64 | (1.81, 7.29) | 0.0003 | 3.31 | (1.56, 7.03) | 0.002 |
| Cervical cancer screening | 2.42 | (1.27, 4.64) | 0.008 | 2.43 | (1.21, 4.86) | 0.01 |
| Medical visit in last 6 months | 1.47 | (1.00, 2.16) | 0.05 | 1.20 | (0.68, 2.10) | 0.5 |
| Currently taking medication | 1.70 | (0.92, 3.13) | 0.1 | 1.30 | (0.55, 3.08) | 0.5 |
aAdjusted for age (categorized at above/below age 40 years), marital status (categorized as currently married vs not), and gender. As cervical cancer screening rates were only calculated among female participants, the adjusted results for this outcome were not adjusted for gender
Relationship between microfinance group membership, health screening, and disease management, stratified by gender and socioeconomic status among 300 residents of two communities in rural western Kenya, 2018–2019
| Women ( | Men ( | Low wealthb | High wealthb | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PR (95% CI) | p | PR (95% CI) | PR (95% CI) | PR (95% CI) | ||||||||
| Current NHIF coverage | 1.61 | (0.73, 3.53) | 0.2 | 1.09 | (0.26, 4.64) | 0.9 | 1.60 | (0.51, 4.97) | 0.4 | 1.16 | (0.42, 3.18) | 0.8 |
| HIV screening | 1.21 | (1.08, 1.35) | 0.007 | 1.26 | (1.10, 1.44) | < 0.0001 | 1.32 | (1.16, 1.51) | < 0.0001 | 1.11 | (0.97, 1.25) | 0.1 |
| Diabetes screening | 3.12 | (2.16, 4.50) | < 0.0001 | 4.00 | (2.74, 5.86) | < 0.0001 | 3.22 | (2.17, 4.79) | < 0.0001 | 3.06 | (2.06, 4.54) | < 0.0001 |
| Hypertension screening | 1.67 | (1.40, 1.98) | < 0.0001 | 2.67 | (2.02, 3.52) | < 0.0001 | 2.10 | (1.68, 2.62) | < 0.0001 | 1.88 | (1.52, 2.33) | < 0.0001 |
| Tuberculosis screening | 2.20 | (1.02, 4.78) | 0.02 | 12.23 | (2.56, 58.46) | 0.002 | 3.19 | (1.24, 8.26) | 0.02 | 3.63 | (1.26, 10.43) | 0.02 |
| Cervical cancer screening | – | – | – | – | – | – | 2.38 | (0.93, 6.10) | 0.07 | 2.35 | (1.04, 5.30) | 0.04 |
| Medical visit in last 6 months | 1.67 | (0.98, 2.82) | 0.06 | 1.20 | (0.84, 1.72) | 0.3 | 1.37 | (0.82, 2.31) | 0.2 | 1.40 | (0.57, 3.42) | 0.6 |
| Currently taking medication | 1.94 | (0.95, 3.96) | 0.07 | 1.00 | (0.20, 4.95) | 1.0 | 1.65 | (0.77, 3.53) | 0.2 | 1.17 | (0.23, 5.95) | 0.9 |
aWald p-values for interaction terms between gender and microfinance group membership were < 0.05 for the tuberculosis screening outcome only
bWald p-values for interaction terms between gender and household wealth asset (dichotomized at median) were < 0.05 for the HIV screening outcome only
Association between duration of microfinance group membershipa and key health screening and disease management outcomes, among current microfinance group members (n = 96)
| PR | |||
|---|---|---|---|
| Current NHIF coverage | 1.38 | (0.40, 4.75) | 0.6 |
| HIV screening | 0.94 | (0.88, 1.00) | 0.05 |
| Diabetes screening | 1.42 | (1.01, 1.98) | 0.04 |
| Hypertension screening | 1.10 | (0.95, 1.28) | 0.2 |
| Tuberculosis screening | 1.09 | (0.42, 2.82) | 0.9 |
| Cervical cancer screening | 1.28 | (0.57, 2.90) | 0.5 |
| Medical visit in last 6 months | 0.83 | (0.58, 1.19) | 0.3 |
| Currently taking medication | 2.50 | (0.85, 7.31) | 0.1 |
aMicrofinance group membership duration cutpoint at above/below 12 months